ReviewBiomolecules2021

New Avenues for Parkinson's Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota.

Marina Lorente-Picón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.